Allurion Technologies Inc. (ALUR)

USD 0.31

(-1.65%)

Revenue Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual revenue in 2023 was 53.46 Million USD , down -16.73% from previous year.
  • Allurion Technologies Inc.'s latest quarterly revenue in 2024 Q1 was 9.38 Million USD , up 13.98% from previous quarter.
  • Allurion Technologies Inc. reported a annual revenue of 64.21 Million USD in annual revenue 2022, up 67.91% from previous year.
  • Allurion Technologies Inc. reported a annual revenue of 38.24 Million USD in annual revenue 2021, down 0.0% from previous year.
  • Allurion Technologies Inc. reported a quarterly revenue of 11.76 Million USD for 2024 Q2, up 25.36% from previous quarter.
  • Allurion Technologies Inc. reported a quarterly revenue of 18.2 Million USD for 2023 Q3, up 40.43% from previous quarter.

Annual Revenue Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Revenue of Allurion Technologies Inc. (2023 - 2020)

Year Revenue Revenue Growth
2023 53.46 Million USD -16.73%
2022 64.21 Million USD 67.91%
2021 38.24 Million USD 0.0%
2020 - USD 0.0%

Peer Revenue Comparison of Allurion Technologies Inc.

Name Revenue Revenue Difference
Abbott Laboratories 40.1 Billion USD 99.867%
Artivion, Inc. 354 Million USD 84.896%
Avanos Medical, Inc. 673.3 Million USD 92.059%
Butterfly Network, Inc. 65.9 Million USD 18.866%
Butterfly Network, Inc. 65.9 Million USD 18.866%
Bio-Rad Laboratories, Inc. 2.67 Billion USD 97.998%
Boston Scientific Corporation 14.24 Billion USD 99.625%
Perspective Therapeutics, Inc. 7.1 Million USD -652.632%
CONMED Corporation 1.24 Billion USD 95.691%
Edwards Lifesciences Corporation 6 Billion USD 99.11%
Paragon 28, Inc. 216.38 Million USD 75.291%
Glaukos Corporation 314.71 Million USD 83.011%
Globus Medical, Inc. 1.56 Billion USD 96.591%
Inspire Medical Systems, Inc. 624.79 Million USD 91.443%
Integer Holdings Corporation 1.59 Billion USD 96.651%
Medtronic plc 32.36 Billion USD 99.835%
Nevro Corp. 425.17 Million USD 87.425%
Owlet, Inc. 54.01 Million USD 1.005%
Penumbra, Inc. 1.05 Billion USD 94.949%
Vicarious Surgical Inc. - USD -Infinity%
Smith & Nephew plc 5.54 Billion USD 99.036%
Sonendo, Inc. 43.86 Million USD -21.89%
STERIS plc 5.13 Billion USD 98.96%
Stryker Corporation 20.49 Billion USD 99.739%
Vapotherm, Inc. 68.66 Million USD 22.138%
Zimmer Biomet Holdings, Inc. 7.39 Billion USD 99.277%